D-1315-2019 Class II Terminated

Recalled by Inopak Ltd — Ringwood, NJ

FDA drug recall D-1315-2019 was initiated by Inopak Ltd on Apr 22, 2019 and is designated Class II. Reason for recall: CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices. The recall status is terminated (terminated Aug 28, 2024). Affected quantity: 17,850 pounds per batch.

Recall Details

Product Type
Drugs
Report Date
Jun 5, 2019
Initiation Date
Apr 22, 2019
Termination Date
Aug 28, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17,850 pounds per batch

Product Description

Antibacterial Hand Soap, Healthcare 2000, labeled as a) DERMA System CARE SaniClenz Antimicrobial Skin Cleanser (Chlorhexidine Gluconate), 4 x (1 gallon containers), Reorder/REF #JSCG; Manufactured for Crosstex International, Inc.; b) MEDI-WASH CHG Anti-Microbial Hand Wash with Chlorhexidine Gluconate; 1000ML pouches, 8/1000ML pouches per case, Walter G. Legge Co Inc, 444 Central AVE, Peekskill, NY 10566

Reason for Recall

CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.

Distribution Pattern

Nationwide in the USA

Code Information

Batch #: 6802, 6803, 6909, 6655

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1315-2019
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1315-2019. Report a data issue: hello@regdatalab.com.